Vitamins in the prevention or delay of cognitive disability of aging

Current Aging Science

Volumn 7, Issue 3, 2014, Pages 187-213

  Dror, Yosef ^a   Stern, Felicia ^a   Gomori, Moshe J ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Autophagy; Brain integrity; Dementia; Disability; Lipofuscin; Micronutrient; Multivitamin

Indexed keywords

HOMOCYSTEINE; MINERAL; SELENIUM; TRACE ELEMENT; VITAMIN; VITAMIN D;

AGED; AGING; AMINO ACID BLOOD LEVEL; ARTICLE; AUTOPHAGY; BLOOD VESSEL FUNCTION; BRAIN; BRAIN DAMAGE; BRAIN FUNCTION; COGNITION; COGNITIVE DEFECT; DRUG TOLERABILITY; GERIATRIC CARE; HUMAN; LIFESTYLE; MINERAL BLOOD LEVEL; MORBIDITY; MORTALITY; NUTRITION; NUTRITIONAL DEFICIENCY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SELENIUM BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; ADVERSE EFFECTS; AGE; ANIMAL; COGNITION DISORDERS; COMORBIDITY; DIET SUPPLEMENTATION; DIETARY REFERENCE INTAKE; DRUG EFFECTS; LIFE EXPECTANCY; LONGEVITY; METABOLISM; NUTRITIONAL STATUS; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGY; RISK FACTOR; TREATMENT OUTCOME;

AGE FACTORS; AGING; ANIMALS; AUTOPHAGY; BRAIN; COGNITION; COGNITION DISORDERS; COMORBIDITY; DIETARY SUPPLEMENTS; HUMANS; LIFE EXPECTANCY; LIFE STYLE; LONGEVITY; NUTRITIONAL STATUS; RECOMMENDED DIETARY ALLOWANCES; RISK FACTORS; TREATMENT OUTCOME; VITAMINS;

EID: 84928816104     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/1874609808666150201214955     Document Type: Article

References (191)

1. Global Health and Agimg, National Institute of Aging, WHO 2011. http://www.nia.nih.gov/sites/default/files/global_health_and_aging. pdf [Accessed June 2014]
2. [2] Topinkova E. Aging, disability and frailty. Ann Nutr Metab 2008; 52(Suppl 1): 6-11.
3. [3] McNamee P, Bond J, Buck D. Costs of dementia in England and Wales in the 21st century. Br J Psychiat 2001; 179: 261-6.
4. [4] Abbott A. The brain’s decline. Nature 2012; 492: S4-S5.
5. [5] Zheng L, Mack WJ, Chui HC, et al. Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adults. J Am Geriatr Soc 2012; 60: 499-504.
6. [6] Kennedy KM, Raz N. Pattern of normal age-related regional differences in white matter microstructure is modified by vascular risk. Brain Res 2009; 1297: 41-56.
7. [7] Sterns G, Jeans PC, Vandecar V. The effect of vitamin D on linear growth in infancy. J Pediat 1936; 9: 1-10.
8. [8] Jeans PC, Sterns G. The effect of vitamin D on linear growth in infancy. The effect of intake above 1800 USP units daily. J Pediat 1938; 13: 730-40.
9. [9] Riley JC. Estimates of regional and global life expectancy, 1800- 2001. Pop Devel Rev 2005; 31: 537-43.
10. Life expectancy at age 65: by gender; Females years, Europe 1996 – 2007; Males years, Europe 1996 – 2007; available at: http://geocommons.com/overlays/14467; http://geocommons.com/overlays/14504; [Accessed June 2014]
11. [11] Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.
12. [12] Zhang W, Bansback N, Anis AH. Measuring and valuing productivity loss due to poor health: A critical review. Social Sci Med 2011; 72: 185-92.
13. [13] Lenneman J, Schwartz S, Giuseffi DL, Wang C. Productivity and health an application of three perspectives to measuring productivity. J Occup Environ Med 2011; 53: 55-61.
14. European Commission, Healthy Life Years (HLY) 2014. http://ec.europa.eu/health/indicators/healthy_life_years/hly_en.htm#fragment0 [Accessed June 2014].
15. [15] Liu J, Chen G, Song X, Chi I, Zheng X. Trends in disability-free life expectancy among Chinese older adults. J Aging Health 2009; 21: 266-85.
16. [16] Conroy S. Defining frailty – the holy grail of geriatric medicine. J Nutr Health Aging 2009; 13: 389.
17. [17] Mangialasche F, Kivipelto M, Solomon A, Fratiglioni L. Dementia prevention: current epidemiological evidence and future perspective. Alzh Res Ther 2012; 4: 6.
18. [18] Jagger C, Matthews R, Lindesay J, Robinson T, Croft P, Brayne C. The effect of dementia trends and treatments on longevity and disability: a simulation model based on the MRC Cognitive Function and Ageing Study. Age Ageing 2009; 38: 319-25.
19. [19] Carayannis EG. Fostering synergies between information technology and managerial and organizational cognition: the role of knowledge management. Technovation 1999; 19: 219-31.
20. [20] McGuire LC, Ford ES, Ajani UA. Cognitive functioning as a predictor of functional disability in later life. Am J Geriat Psychiat 2006; 14: 36-42.
21. [21] Upadhyaya AK, Rajagopal M, Gale TM. The Six Item Cognitive Impairment Test (6-CIT) as a screening test for dementia: comparison with Mini-Mental State Examination (MMSE). Curr Aging Sci 2010; 3: 138-42.
22. [22] Jitapunkul S, Kunanusont C, Phoolcharoen W, Suriyawongpaisal P, Ebrahim E. Disability-free life expectancy of elderly people in a population undergoing demographic and epidemiologic transition. Age Ageing 2003; 32: 401-5.
23. [23] Vassallo N, Scerri C. Mediterranean diet and dementia of the Alzheimer type. Curr Aging Sci 2013; 6: 150-62.
24. [24] Cigolle CT, Langa KM, Kabeto MU, Tian Z, Blaum CS. Geriatric conditions and disability: The Health and Retirement Study. Ann Inter Med 2007; 147: 156-64.
25. [25] Fotuhi M, Do D, Jack C. Modifiable factors that alter the size of the hippocampus with ageing. Nat Rev Neurol 2012; 8: 189-202.
26. [26] Al Snih S, Ottenbacher KJ, Markides KS, Kuo YF, Eschbach K, Goodwin JS. The effect of obesity on disability vs mortality in older Americans. Arch Inter Med 2007; 167: 774-80.
27. [27] Mathers CD, Sadana R, Salomon JA, Murray CJL, Lopez AD. Healthy life expectancy in 191 countries, 1999. Lancet 2001; 357: 1685-91.
28. [28] Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet 2013; 381: 752-62.
29. [29] Kuoppala J, Lamminpaa A, Vaananen-Tomppo I, Soc L, Hinkka K. Employee well-being and sick leave, occupational accident, and disability pension. J Occup Environ Med 2011; 53: 633-640.
30. [30] Nyberg L, Lovden M, Riklund K, Lindenberger U, Backman L. Memory aging and brain maintenance. Trends Cogn Sci 2012; 16: 292-305.
31. [31] He J, Iosif AM, Lee DY, et al. Brain structure and cerebrovascular risk in cognitively impaired patients. Arch Neurol 2010; 67: 1231-7.
32. [32] Alvesa TCDTF, Ferreira LK, Busatto GF. Vascular diseases and old age mental disorders: an update of neuroimaging findings. Curr Opin Psychiat 2010; 23: 491-7.
33. [33] Smith EE, Schneider JA, Wardlaw JM, Greenberg SM. Cerebral microinfarcts: the invisible esions. Lancet Neurol 2012; 11: 272-82.
34. [34] Fornage M, Debette S, Bis JC, et al. Genome-wide association studies of cerebral white matter lesion burden: the charge consortium. Ann Neurol 2011; 69: 928-39.
35. [35] Debette S. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and metaanalysis. BMJ 2010; 341: c3666.
36. [36] Fratiglioni L, Mangialasche F, Qiu C. Brain aging: lessons from community studies. Nutr Rev 2010; 68: S119-S127.
37. [37] Polyak Z, Stern F, Berner YN, et al. Hyperhomocysteinemia and vitamin score: correlations with silent brain ischemic lesions and brain atrophy. Dement Geriatr Cogn Disord 2003; 16: 39-45.
38. [38] Dufouil C, Alperovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003; 53: 214-21.
39. [39] Den Heijer T, Vermeer SE, Clarke R, et al. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 2003; 126: 170-5.
40. [40] Whalley LJ, Staff RT, Murray AD, et al. Plasma vitamin C, cholesterol and homocysteine are associated with grey matter volume determined by MRI in non-demented old people. Neurosci Lett 2003; 341: 173-6.
41. [41] Scott TM, Tucker KL, Bhadelia A, et al. Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders. Am J Geriat Psychiat 2004; 12: 631-8.
42. [42] Vogiatzoglou A, Refsum H, Johnston C, et al. Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology 2008; 71: 826-32.
43. [43] De Lau LML, Refsum H, Smith AD, Johnston C, Breteler MMB. Plasma folate concentration and cognitive performance: Rotterdam Scan Study. Am J Clin Nutr 2007; 86: 728-34.
44. [44] De Lau LML, Smith AD, Refsum H, Johnston C, Breteler MMB. Plasma vitamin B12 status and cerebral white-matter lesions. J Neurol Neurosurg Psychiatry 2009; 80: 149-57.
45. [45] Buell JS, Dawson-Hughes B, Scott TM, et al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010; 74: 18-26.
46. [46] Poly C, Massaro JM, Seshadri S, et al. The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort. Am J Clin Nutr 2011; 94: 1584-91.
47. [47] Brundel M, De Bresser J, Van Dillen JJ, Kappelle LJ, Biessels GJ. Cerebral microinfarcts: a systematic review of neuropathological studies. J Cerebral Blood Flow Metabol 2012; 32: 425-36.
48. [48] Martino G, Pluchino S, Bonfanti L, Schwartz M. Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells. Physiol Rev 2011; 91: 1281-304.
49. [49] Yiu G, He Z. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 2006; 7: 617-27.
50. [50] Martinez A, Portero-Otin M, Pamplona R, Ferrer I. Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathol 2010; 20: 281-97.
51. [51] Hohn A, Jung T, Grimm S, Grune T. Lipofuscin-bound iron is a major intracellular source of oxidants: role in senescent cells. Free Rad Biol Med 2010; 48: 1100-8.
52. [52] Butterfield DA, Kanski J. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Develop 2001; 122: 945-62.
53. [53] Double KL, Dedov VN, Fedorow H, et al. The comparative biology of neuromelanin and lipofuscin in the human brain. Cell Mol Life Sci 2008; 65: 1669-82.
54. [54] Komatsu F, Kagawa Y, Kawabata T, et al. Influence of essential trace minerals and micronutrient insufficiencies on harmful metal overload in a Mongolian patient with multiple sclerosis. Curr Aging Sci 2012; 5: 112-25.
55. [55] Keller JN, Dimayuga E, Chen Q, Thorpe J, Gee J, Ding Q. Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Inter J Biochem Cell Biol 2004; 36: 2376-91.
56. [56] Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42.
57. [57] Rubinsztein DC, Marino G, Kroemer G. Autophagy and aging. Cell 2011; 146: 682-95.
58. [58] Amani S, Naeem A. Understanding protein folding from globular to amyloid state aggregation: darker side of protein. Proc Biochem 2013; 48: 1651-64.
59. [59] Chondrogianni N, Petropoulos I, Grimm S, et al. Protein damage, repair and proteolysis. Mol Aspects Med 2014; 35: 1-71.
60. [60] Salminen A, Kaarniranta K, Annakaisa H, Soininen H, Hiltunen M. AMP-activated protein kinase: a potential player in Alzheimer's disease. J Neurochem 2011; 118: 460-74.
61. Salminen A, Kaarniranta K, Kauppinen A, et al. Impaired autophagy and APP processing in Alzheimer’s disease: the potential role of beclin 1 interactome. Prog Neurobiol 2013; (106-107): 33-54.
62. [62] Lee SJ, Koh JY. Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes. Mol Brain 2010; 3: 30.
63. [63] Galluzzi L, Pietrocola F, Levine B, Kroemer G. Metabolic control of autophagy. Cell 2014; 159: 1263-76.
64. [64] Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011; 147: 728-41.
65. [65] Salminen A, Kaarniranta K. SIRT1: Regulation of longevity via autophagy. Cell Signal 2009; 21: 1356-60.
66. [66] Pallauf K, Rimbach G. Autophagy, polyphenols and healthy ageing. Ageing Res Rev 2013; 12: 237-52.
67. [67] Petrovski G, Das DK. Does autophagy take a front seat in lifespan extension? J Cell Mol Med 2010; 14: 2543-51.
68. [68] Decuypere JP, Bultynck G, Parys JB. A dual role for Ca2+ in autophagy regulation. Cell Calcium 2011; 50: 242-50.
69. [69] Rajawat Y, Hilioti Z, Bossis I. Autophagy: a target for retinoic acids. Autophagy 2010; 6: 1224-6.
70. [70] Singletary K, Milner J. Diet, autophagy, and cancer. Cancer Epidemiol Biomarks Prev 2008; 17: 1596-610.
71. [71] Fabri M, Modlin RL. A vitamin for autophagy. Cell Host Microbe 2009; 6: 201-3.
72. [72] Wang J, Lian H, Zhao Y, Kauss MA, Spinde S. Vitamin D3 Induces autophagy of human myeloid leukemia cells. J Biol Chem 2008; 283: 25596-605.
73. [73] Afacan NJ, Fjell CD, Hancock REW. A systems biology approach to nutritional immunology – focus on innate immunity. Mol Aspects Med 2012; 33: 14-25.
74. [74] Campbell GR, Spector SA. Vitamin D inhibits human immunodeficiency virus type 1 and mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog 2012; 8: e1002689.
75. [75] Hoyer-Hansen M, Nordbrandt SPS, Jaattela M. Autophagy as a basis for the health-promoting effects of vitamin D. Trends Mol Med 2010; 16: 295-302.
76. [76] Martin A, Joseph JA, Cuervo AM. Stimulatory effect of vitamin C on autophagy in glial cells. J Neurochem 2002; 82: 538-49.
77. [77] Karim MR, Fujimura S, Kadowaki M. Vitamin E as a novel enhancer of macroautophagy in rat hepatocytes and H4-II-E cells. Biochem Biophys Res Comm 2010; 394: 981-7.
78. [78] Yokoyama T, Miyazawa K, Naito M, et al. Vitamin K2 induces autophagy and apoptosis simultaneously in leukemia cells. Autophagy 2008; 4: 629-40.
79. [79] Brunk UT, Terman AA. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radical Biol Med 2002; 33: 611-9.
80. [80] Yuk JM, Shin DM, Lee HM, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009; 6: 231-43.
81. [81] Tomasetti M, Nocchi L, Neuzil J, et al. Alpha-tocopheryl succinate inhibits autophagic survival of prostate cancer cells induced by vitamin K3 and ascorbate to trigger cell death. PLoS One 2012; 7: e52263.
82. [82] Hannigan AM, Gorski SM. Macroautophagy. Autophagy 2009; 5: 140-51.
83. [83] Cuervo AM, Bergamini E, Brunk UT, Droge W, Ffrench M, Terman A. Autophagy and aging. Autophagy 2005; 1: 131-40.
84. [84] Jimenez C, Leets I, Puche R, et al. A single dose of vitamin A improves haemoglobin concentration, retinol status and phagocytic function of neutrophils in preschool children. Br J Nutr 2010; 103: 798-802.
85. [85] Slemmer JE, Shacka JJ, Sweeney MI, Weber JT. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr Med Chem 2008; 15: 404-14.
86. [86] Bian Z, Furuya N, Zheng DM, et al. Ferulic acid induces mammalian target of rapamycin inactivation in cultured mammalian cells. Biol Pharm Bull 2013; 36: 120-4.
87. [87] Vingtdeux V, Giliberto L, Zhao H, et al. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-β peptide metabolism. J Biol Chem 2010; 285: 9100-3.
88. [88] Linko AM, Juntunen KS, Mykkanen HM, Adlercreutz H. Wholegrain rye bread consumption by women correlates with plasma alkylresorcinols and increases their concentration compared with low-fiber wheat bread. J Nutr 2005; 135: 580-3.
89. [89] Ostadalova I, Charvatova Z, Wilhelm J. Lipofuscin-like pigments in the rat heart during early postnatal development: effect of selenium supplementation. Physiol Res 2010; 59: 881-6.
90. [90] Paris I, Perez-Pastene C, Couve E, Caviedes P, LeDoux S, Segura- Aguilar J. Copper dopamine complex induces mitochondrial autophagy preceding caspase-independent apoptotic cell death. J Biol Chem 2009; 284: 13306-15.
91. [91] Kiselyov K, Colletti GA, Terwilliger A, et al. TRPML: transporters of metals in lysosomes essential for cell survival? Cell Calcium 2011; 50: 288-94.
92. [92] Wang B, Brand-Miller J. The role and potential of sialic acid in human nutrition. Eur J Clin Nutr 2003; 57: 1351-69.
93. [93] Parajuli N, MacMillan-Crow LA. Role of reduced manganese superoxide dismutase in ischemia-reperfusion injury: a possible trigger for autophagy and mitochondrial biogenesis? Am J Physiol 2013; 304: F257-F67.
94. [94] Ngwa HA, Kanthasamy A, Gu Y, Fang N, Anantharam V, Kanthasamy AG. Manganese nanoparticle activates mitochondrial dependent apoptotic signaling and autophagy in dopaminergic neuronal cells. Toxicol App Pharmacol 2011; 256: 227-40.
95. [95] Berner YN, Stern F, Polyak Z, Dror Y. Dietary intake analysis in institutionalized elderly: a focus on nutrient density. J Nutr Health Aging 2002; 6: 275-82.
96. [96] Kurz T, Eaton JW, Brunk UT. Redox activity within the lysosomal compartment: implications for aging and apoptosis. Antioxid Redox Signal, 2010; 13: 511-23.
97. [97] Kurz T, Eaton JW, Brunk UT. The role of lysosomes in iron metabolism and recycling. Inter J Biochem Cell Biol 2011; 43: 1686-97.
98. [98] Stern F, Berner YN, Polyak Z, et al. Homocysteine effect on protein degradation rates. Clin Biochem 2004; 37: 1002-9.
99. [99] Nixon RA, Cataldo AM. The lysosomal system in neuronal cell death. Ann NY Acad Sci 1993; 679: 87-109.
100. [100] De Jager CA. Critical levels of brain atrophy associated with homocysteine and cognitive decline. Neurobiol Aging 2014; 35: S35-S9.
101. [101] Ganji V, Kafai MR. Population reference values for plasma total homocysteine concentrations in US adults after the fortification of cereals with folic acid. Am J Clin Nutr 2006; 84: 989-94.
102. [102] Solfrizzi V, DIntrono A, Colacicco AM, et al. Circulating biomarkers of cognitive decline and dementia. Clin Chim Acta 2006; 364: 91-112.
103. [103] Nilsson K, Gustafson L, Hultberg B. Plasma homocysteine, brain imaging and cognition in older patients with mental illness. Int J Geriatr Psychiat 2012; 27: 409-14.
104. [104] Xiong YY, Mok V. Age-related white matter changes in Asia. Neurology Asia 2011; 16: 179-86.
105. [105] Linnebank M, Popp J, Smulders Y, et al. S-Adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer’s disease. Neurodegener Dis 2010; 7: 373-8.
106. [106] Ferry M, Roussel AM. Micronutrient status and cognitive decline in ageing. Eur Geriatr Med 2011; 2: 15-21.
107. [107] Klonizakis M, Alkhatib A, Middleton G. Long-term effects of an exercise and Mediterranean diet intervention in the vascular function of an older, healthy population. Microvasc Res 2014; 95: 103-7.
108. [108] Odermarsky M, Lykkesfeldt J, Liuba P. Poor vitamin C status is associated with increased carotid intima-media thickness, decreased microvascular function, and delayed myocardial repolarization in young patients with type 1 diabetes. Am J Clin Nutr 2009; 90: 447-52.
109. [109] Wong MSK, Leisegang MS, Kruse C, et al. Vitamin D promotes vascular regeneration. Circulation 2014; 130: 976-86.
110. [110] Cuevas AM, Germain AM. Diet and endothelial function. Biol Res 2004; 37: 225-30.
111. [111] Ashor AW, Siervo M, Lara J, Oggioni C, Mathers JC. Antioxidant vitamin supplementation reduces arterial stiffness in adults: a systematic review and meta-analysis of randomized controlled trials. J Nutr 2014; 144: 1594-602.
112. [112] Kaplon RE, Gano LB, Seals DR. Vascular endothelial function and oxidative stress are related to dietary niacin intake among healthy middle-aged and older adults. J Appl Physiol 2014; 116: 156-63.
113. [113] Yamagata K, Tagami M, Yamori Y. Dietary polyphenols regulate endothelial function and prevent cardiovascular disease. Nutrition 2015; 31: 28-37.
114. [114] Taylor CL. Framework for DRI development. Health Canada, Ottawa, Ontario 2008.
115. [115] Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Laboratory reference values. N Engl J Med 2004; 351: 1548-63.
116. Harrison's Online, Featuring the complete contents of Harrison's Principles of Internal Medicine, Appendix, 18e; available at: http://accessmedicine.mhmedical.com/content.aspx?bookid=331&s ectionid=40727226.[Accessed June 2014]
117. [117] Berdanier CD, Feldman EB, Dwyer J, Eds. Handbook of nutrition and food, 2nd Ed, CRC Press 2007.
118. [118] Volkert D, Stehle P. Vitamin status of elderly people in Germany. Int J Vitam Nutr Res 1999; 69: 154-9.
119. [119] McLernon PC, Wood LG, Murphy VE, Hodyl NY, Clifton VL. Circulating antioxidant profile of pregnant women with asthma. Clin Nutr 2012; 31: 99-107.
120. [120] Mock DM, Malik MI. Distribution of biotin in human plasma: most of the biotin is not bound to protein. Am J Clin Nutr 1992; 56: 427-32.
121. [121] Ilcol YO, Basagan-Mogol E, Cengiz M, Ulus IH. Elevation of serum cerebral injury markers correlates with serum choline decline after coronary artery bypass grafting surgery. Clin Chem Lab Med 2006; 44: 471-8.
122. [122] Zou Z, Xu X. Huang Y, et al. High serum level of lutein may be protective against early atherosclerosis: The Beijing atherosclerosis study. Atherosclerosis 2011; 19: 789-93.
123. BioLab Medical Unit. Nutritional and Environmental Medicine, Laboratory Guide. Number 7.5–October 2006. London.
124. [124] Cockle SM, Haller, J, Kimber S, Dawe RA, Hindmarch I. The influence of multivitamins on cognitive function and mood in the elderly. Aging Mental Health 2000; 4: 339-53.
125. [125] Dror Y, Giveon SM, Hoshen M, Feldhamer I, Balicer RD, Feldman BS. Vitamin D levels for preventing acute coronary syndrome and mortality: evidence of a nonlinear association. J Clin Endocrinol Metab 2013; 98: 2160-7.
126. [126] Druesne-Pecollo N, Latino-Martel P, Norat T, et al. Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials. Int J Cancer 2010; 127: 172-84.
127. [127] Wilson CJ, Apiyo D, Wittung-Stafshede P. Role of cofactors in metalloprotein folding. Quart Rev Biophys 2004; 37: 285-314.
128. [128] Michalke B, Nischwitz V. Review on metal speciation analysis in cerebrospinal fluid—current methods and results: a review. Anal Chim Acta 2010; 682: 23-36.
129. [129] Bostrom F, Hansson O, Gerhardsson L, et al. CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies. Neurobiol Aging 2009; 30: 1265-71.
130. [130] Rossipal E, Krachler M. Pattern of trace elements in human milk during the course of lactation. Nutr Res 1998; 18: 11-24.
131. [131] Almeida AA, Lopes CMPV, Silva AMS, Barrado E. Trace elements in human milk: correlation with blood levels, inter-element correlations and changes in concentration during the first month of lactation. J Trace Elems Med Biol 2008; 22: 196-205.
132. [132] Yamawaki N, Yamada M, Kan-no T, Kojima T, Kaneko T, Yonekubo A. Macronutrient, mineral and trace element composition of breast milk from Japanese women. J Trace Elem Med Biol 2005; 19: 171-81.
133. [133] Nicolis I, Curis E, Deschamps P, Benazeth S. Arsenite medicinal use, metabolism, pharmacokinetics and monitoring in human hair. Biochimie 2009; 91: 1260-7.
134. [134] Willey JZ, Moon YP, Paik MC, et al. Lower prevalence of silent brain infarcts in the physically active: The Northern Manhattan Study. Neurology 2011; 76: 2112-8.
135. [135] Debette S, Seshadri S, Beiser A, et al. Wolf PA, DeCarli C. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011; 77: 461-8.
136. [136] Prasad KN, Bondy SC. Inhibition of early upstream events in prodromal Alzheimer’s disease by use of targeted antioxidants. Curr Aging Sci 2014; 7: 77-90.
137. [137] Wacker M, Holick MF. Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 2013; 5: 111-48.
138. [138] Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008; 168: 1629-37.
139. [139] Michaelsson K, Baron JA, Snellman G, et al. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 2010; 92: 841-8.
140. [140] Taylor CL, Carriquiry AL, Bailey RL, Sempos CT, Yetley EA. Appropriateness of the probability approach with a nutrient status biomarker to assess population inadequacy: a study using vitamin D. Am J Clin Nutr 2013; 97: 72-8.
141. [141] Eisman JA. When is a U-curve actually a J-curve? Is it really too much of a good thing? J Clin Endocrinol Metab 2013; 98: 1863-4.
142. [142] Sempos CT, Durazo-Arvizu RA, Dawson-Hughes B, et al. Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? J Clin Endocrinol Metab 2013; 98: 3001-9.
143. [143] Wald DS, Kasturiratne A, Simmonds M. Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants. Alzheimers Dement 2011; 7: 412-7.
144. [144] Soumare A, Elbaz A, Ducros V, Tavernier B, Alperovitch A, Tzourio C. Cross-sectional association between homocysteine and motor function in the elderly. Neurology 2006; 67: 985-90.
145. [145] Elias MF, Robbins MA, Budge MM, et al. Homocysteine, folate, and vitamins B6 and B12 blood levels in relation to cognitive performance: the maine-syracuse study. Psychosom Med 2006; 68: 547-54.
146. [146] Salerno-Kennedy R, Cashman KD. Relationship between dementia and nutrition-related factors and disorders: an overview. Int J Vitam Nutr Res 2005; 75: 83-95.
147. [147] Kim J, Park MH, Kim E, Han C, Jo SA, Jo I. Plasma homocysteine is associated with the risk of mild cognitive impairment in an elderly Korean population. J Nutr 2003; 137: 2093-7.
148. [148] Ku BD, Na DL, Moon SY, et al. Neuropsychological correlates of the proportional impact of white matter hyperintensities on mild to moderate dementia: The MRI 300 Study. Dement Geriatr Cogn Disord 2011; 31: 397-405.
149. [149] Brickman AM, Meier IB, Korgaonkar MS, et al. Testing the white matter retrogenesis hypothesis of cognitive aging. Neurobiol Aging 2012; 33: 1699-715.
150. [150] Plassman BL, Williams Jr. JW, Burke JR, Holsinger T, Benjamin S. Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med 2010; 153: 182-93.
151. [151] Kesse-Guyot R, Fezeu L, Jeandel C, et al. French adults’ cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the supplementation in vitamins and mineral antioxidants (SU.VI.MAX) trial. Am J Clin Nutr 2011; 94: 892-99.
152. [152] Benton D, Griths R, Haller J. Thiamine supplementation mood and cognitive functioning. Psychopharmacology 1997; 129: 66-71.
153. [153] Benton D, Fordy J, Haller J. The impact of long-term vitamin supplementation on cognitive functioning. Psychopharmacology 1995; 117: 298-305.
154. [154] Haller J, Lowik MRH, Ferry M, Ferro-Luzzi A. Nutritional Status: vitamins A, E, B6, B12, Folic acid, and carotene. Eur J Clin Nutr 1991; 45: 63-82.
155. [155] Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro III A. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr 2005; 82: 627-35.
156. [156] Ross AC, Manson JAE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53-58.
157. [157] Dawson-Hughes B, Harris SS. High-dose Vitamin D supplementation. Too much of a good thing? JAMA 2010; 303: 1861-2.
158. [158] Agostoni C, Bresson JL, Fairweather-Tait S, et al. Scientific opinion on the tolerable upper intake level of vitamin D1. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). EFSA J 2012; 10: 2813.
159. [159] Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer. JAMA 2005; 294: 56-65.
160. [160] Hathcock JN, Azzi A, Blumberg J, et al. Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr 2005; 81: 736-45.
161. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2008; Issue 2: CD007176.
162. [162] Miller ER III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142: 37-46.
163. [163] Traber MG. Vitamin E and K interactions – a 50-year-old problem. Nutr Rev 2008; 66: 624-9.
164. [164] Booth SL, Golly I, Sacheck JM, et al. Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status. Am J Clin Nutr 2004; 80: 143-8.
165. [165] Pauling L. Are recommended daily allowances for vitamin C adequate. Proc Natl Acad Sci USA 1974; 71: 4442-6.
166. [166] Dror Y, Stern F. Micronutrient supplementation in the elderly. AgroFood Indu-hi-tech 2004; 16: 30-2.
167. [167] Bjelakovic G, Nikolova D, Gluud L, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007; 297: 842-57.
168. [168] Lonn E, Yusuf S, Hoogwerf B, et al. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes. Diabetes Care 2002; 25: 1919-27.
169. [169] Thomas LDK, Elinder CF, Tiselius HG, Wolk A, Akesson A. Ascorbic acid supplements and kidney stone incidence among men: a prospective study. JAMA Int Med 2013; 173: 386-8.
170. [170] Goodman GE, Thornquist MD, Balmes J, et al. The β-carotene and retinol efficacy trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping β-carotene and retinol supplements. J Natl Cancer Inst 2004; 96: 1743-50.
171. [171] Mazdak H, Yazdekhasti F, Movahedian A, Mirkheshti N, Shafieian M. The comparative study of serum iron, copper, and zinc levels between bladder cancer patients and a control group. Int Urol Nephrol 2010; 42: 89-93.
172. [172] Bleys J, Navas-Acien A, Laclaustra M, et al. Serum selenium and peripheral arterial disease: results from the National Health and Nutrition Examination Survey, 2003–2004. Am J Epidemiol 2009; 169: 996-1003.
173. [173] Laclaustra M, Navas-Acien A, Stranges S, Ordovas JM, Guallar E. Serum selenium concentrations and diabetes in U.S. adults: national health and nutrition examination survey (NHANES) 2003– 2004. Environ Health Perspect 2009; 117: 1409-13.
174. [174] Laclaustra M, Navas-Acien A, Stranges S, Ordovas JM, Guallar E. Serum selenium concentrations and hypertension in the US population. Circ Cardiovasc Qual Outcomes 2009; 2: 369-76.
175. [175] Fairweather-Tait SJ, Bao Y, Broadley MR, et al. Selenium in human health and disease. Antioxid Redox Signal 2011; 14: 1337-83.
176. [176] Li S, Xiao T, Zheng B. Medical geology of arsenic, selenium and thallium in China. Sci Total Environ 2012; 421-422: 31-40.
177. [177] Chiang EC, Shen S, Kengeri SS, et al. Defining the optimal selenium dose for prostate cancer risk reduction: insights from the Ushaped relationship between selenium status, DNA damage, and apoptosis. Dose-Response 2010; 8: 285-300.
178. [178] Navas-Acien A, Bleys J, Guallar E. Selenium intake and cardiovascular risk: what is new? Curr Opin Lipidol 2008, 19: 43-9.
179. [179] Bates CJ. Diagnosis and detection of vitamin deficiencies. Br Med Bull 1999; 55: 643-57.
180. [180] Lewis SM, Mayhugh MA, Freni SC, et al. Assesment and significance of 24-h energy intake pattern among young and aged nonaffluent southern US women. J Nutr Health Aging 2003; 7: 78-83.
181. [181] Lammes E, Akner G. Repeated assessment of energy and nutrient intake in 52 nursing home residents. J Nutr Health Aging 2006; 10: 222-30.
182. [182] Suominen M, Laine A, Routasalo P, Pitkala KH, Rasanen L. Nutrient content of served food, nutrient intake and nutritional status of residents with dementia in a Finnish nursing home. J Nutr Health Aging 2004; 8: 234-8.
183. [183] Rolland Y, Pillard F, Garrigue E, Amouyal K, Riviere D, Vellas B. Nutritional intake and recreational physical activity in healthy elderly women living in the community. J Nutr Health Aging 2005; 9: 397-402.
184. [184] Tur JA, Colomer M, Monino M, Bonnin T, Llompart I, Pons SA. Dietary intake and nutritional risk among free-living elderly people in Palma de Mallorca. J Nutr Health Aging 2005; 9: 390-6.
185. [185] Aghdassi E, McArthur M, Liu B, McGeer A, Simor A, Allard JP. Dietary intake of elderly living in Toronto long-term care facilities: comparison to the dietary reference intake. Rejuvenation Res 2007; 10: 301-9.
186. [186] Liu BA, McGeer A, McArthur MA, et al. Effect of multivitamin and mineral supplementation on episodes of infection in nursing home residents: a randomized, placebo-controlled study. J Am Geriatr Soc 2007; 55: 35-42.
187. [187] Dumartheray EW, Krieg MA, Cornuz J, Whittamore DR, Lanham- New SA, Burckhardt P. Energy and nutrient intake of Swiss women aged 75–87 years. J Hum Nutr Diet 2006; 19: 431-5.
188. [188] Tome MJM, Rodriguez A, Jimenez AM, Mariscal M, Murcia MA, Garcia-Diz L. Food habits and nutritional status of elderly people living in a Spanish Mediterranian city. Nutr Hosp 2011; 26: 1175-83.
189. [189] Sebastian RS, Cleveland LE, Goldman JD, Moshfegh AJ. Older adults who use vitamin/mineral supplements differ from nonusers in nutrient intake adequacy and dietary attitudes. J Am Diet Assoc 2007; 107: 1322-32.
190. [190] Lichtenstein AH, Rasmussen H, Yu WW, Epstein SR, Russell RM. Modified My Pyramid for older adults. J Nutr 2008; 138: 5-11.
191. [191] Dror Y, Stern F, Berner YN, et al. Recommended micronutrient supplementation for institutionalized elderly. J Nutr Health Aging 2002; 6: 295-300.